TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PEPTONIC medical AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
37,118
|
43,634
|
31,643 |
Financial expenses |
2,323
|
5,564
|
72 |
Earnings before taxes |
-42,589
|
-36,857
|
-73,688 |
EBITDA |
-34,920
|
-30,115
|
-46,663 |
Total assets |
106,736
|
85,752
|
83,500 |
Current assets |
40,415
|
31,354
|
27,086 |
Current liabilities |
31,413
|
35,065
|
31,483 |
Equity capital |
75,323
|
47,092
|
52,017 |
- share capital |
38,371
|
24,274
|
19,164 |
Employees (average) |
37
|
33
|
34 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
70.6%
|
54.9%
|
62.3% |
Turnover per employee |
1,003
|
1,322
|
931 |
Profit as a percentage of turnover |
-114.7%
|
-84.5%
|
-232.9% |
Return on assets (ROA) |
-37.7%
|
-36.5%
|
-88.2% |
Current ratio |
128.7%
|
89.4%
|
86.0% |
Return on equity (ROE) |
-56.5%
|
-78.3%
|
-141.7% |
Change turnover |
-6,516
|
11,991
|
10,360 |
Change turnover % |
-15%
|
38%
|
49% |
Chg. No. of employees |
4
|
-1
|
15 |
Chg. No. of employees % |
12%
|
-3%
|
79% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.